Dairy at bedtime could be affecting your sleep
New studies have shown that consuming cheese could be causing disturbed sleep and frequent nightmares.
Experts say they have found a strong link between getting nighttime terrors and having a form of lactose intolerance.
Researchers questioned more than 1,000 students at Canada's MacEwan University about their sleep, eating habits, and any perceived tie between the two.
Almost a third of those asked admitted to having regular nightmares with the majority of these respondents women.
Females were also more likely to remember their dreams and nearly twice as likely as men to know that they had a food allergy or intolerance.
40 per cent of the students said they thought that eating late at night or eating specific foods had affected their sleep, while a quarter believed that consuming certain foods could make their sleep worse.
The study found that people with less healthy diets were more likely to have bad dreams and less likely to remember their dreams.
From comparing the data collated, the experts compared reports of food intolerances to those of bad dreams and poor sleep, and found that 'lactose intolerance was associated with gastrointestinal symptoms, nightmares, and low sleep quality'.
Lead researcher Dr Tore Nielsen, who helped collate the findings from the University of Montreal, said: 'Nightmare severity is robustly associated with lactose intolerance and other food allergies.
'These new findings imply that changing eating habits for people with some food sensitivities could alleviate nightmares. They could also explain why people so often blame dairy for bad dreams.
'Nightmares are worse for lactose-intolerant people who suffer severe gastrointestinal symptoms and whose sleep is disrupted. This makes sense, because we know that other bodily sensations can affect dreaming.'
Some 'grate' advice has been issued by top scientists who think they may have found the remedy to enjoying a peaceful night of slumber.
Stomach pain from consuming dairy before laying down for the night plus gas during the night can affect sleep, researchers say, adding that the way to a getting a fully rested night could be as simple as cutting out cheese.
Not consuming the dairy product could help improve sleep quality, which may already be disrupted thanks to a number of outside factors such as noise and light pollution or other health issues.
Now, the authors are hoping to continue their studies to get a more in depth look at the impact certain foods have on our sleep quality.
Nielsen added: 'We need to study more people of different ages, from different walks of life, and with different dietary habits to determine if our results are truly generalizable to the larger population.'
The full findings have been published in journal Frontiers in Psychology.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study
TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ('Revive' or the 'Company') (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialized life sciences company dedicated to the research and development of therapeutics for infectious diseases and medical countermeasures, hereby clarifies its update regarding the research study assessing Bucillamine as a potential treatment for nerve agent exposure. This study is being conducted in collaboration with Defence R&D Canada – Suffield Research Centre ('DRDC'), an agency of the Canadian Department of National Defence, which is investigating pharmacological compounds, including Bucillamine, capable of mitigating nerve agent-induced brain injury. The research study with Bucillamine is slated for continuation through September 2025, and its findings will be disseminated exclusively with the express authorization of the DRDC. The Company affirms that future research endeavours with DRDC have not been broached and would only be deliberated subsequent to the conclusion of the current research study and contingent upon the satisfactory nature of its results, warranting further investigation. About Revive Therapeutics Ltd. Revive Therapeutics is a life sciences company focused on the research and development of therapeutics for infectious diseases and medical countermeasures. Revive prioritizes its drug development efforts to take advantage of several regulatory incentives awarded by the FDA, such as Emergency Use Authorization, Orphan Drug, Fast Track, and Breakthrough Therapy designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. Revive is also advancing the development of Psilocybin and molecular hydrogen therapeutics through various programs. For more information, visit For more information, please contact: Michael FrankChief Executive OfficerRevive Therapeutics 1 888 901 0036Email: mfrank@ Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of this release. Cautionary Statement This press release contains 'forward-looking information' within the meaning of applicable Canadian securities legislation. These statements relate to future events or future performance. The use of any of the words 'may', 'could', 'intend', 'expect', 'believe', 'will', 'projected', 'estimated' and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on Revive's current belief or assumptions as to the outcome and timing of such future events. Forward looking information in this press release includes information with respect to the Company's cannabinoids, psychedelics and infectious diseases programs. Forward-looking information is based on reasonable assumptions that have been made by Revive at the date of the information and is subject to known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated in the forward-looking information. Given these risks, uncertainties and assumptions, you should not unduly rely on these forward-looking statements. The forward-looking information contained in this press release is made as of the date hereof, and Revive is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. The foregoing statements expressly qualify any forward-looking information contained herein. Reference is made to the risk factors disclosed under the heading 'Risk Factors' in the Company's management's discussion and analysis for the three and nine months ended March 31, 2025 ("MD&A"), dated May 29, 2025, which is available on the Company's profile at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Connexall Now Available in Epic Toolbox as Alert Manager Solution
Milestone Underscores Connexall's Seamless Integration with Epic for Clinical Alerting and Interoperability TORONTO, July 08, 2025--(BUSINESS WIRE)--Connexall, a global leader in clinical communication, alarm management, and workflow optimization, today announced its designation in the "Alert Manager Integration" category in Epic Toolbox on Showroom. This achievement highlights Connexall's expertise in driving seamless integration with disparate systems to provide intelligently routed clinical and operational alerts directly into Epic – including Rover, Haiku, and Canto. Connexall collaborated with Epic to provide input into the design of the Alert Manager Integration blueprint, which defines Epic's recommended practices for products in this category. Within Showroom, Toolbox is a designation for products that use established integration technology in select categories to meet Epic defined recommended connection practices for that area. The eligible categories focus on the most impactful and innovative areas for Epic customers. Connexall's integration platform provides deep interoperability and proven outcomes for health systems looking to streamline alert management and reduce alarm fatigue. "This recognition by Epic demonstrates Connexall's commitment to improving clinical workflows, patient safety, and staff and clinician satisfaction for over 25 years," said Connexall CEO Sandy Saggar. "We are honored to support the standard in the Alert Manager Integration category in the Epic Toolbox." With its extensive integration library, Connexall offers bi-directional integration with Epic and consolidates alerts from various systems—such as nurse call, patient monitoring, IV pumps, RTLS, and smart beds—ensuring the right information reaches the right care team member, on the right device, at the right time. This milestone reaffirms Connexall's role in the healthcare ecosystem—alleviating burden, increasing efficiency, and improving patient care. About Connexall Connexall is a connected care and interoperability platform, seamlessly integrating disparate healthcare technologies. As a vendor-neutral solution, Connexall intelligently manages alarms and optimizes workflows to improve staff experience and patient safety. To learn more, visit Epic, Rover, Canto, and Haiku are registered trademarks of Epic Systems Corporation. View source version on Contacts Media Contact: Amira Melnichenkoamelnichenko@ 321-247-3940 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
Ancient Menominee grew tropical corn farther north than expected, surprising researchers
In a stunning discovery — both in agricultural sophistication and geographic location — researchers have found ancestors of the Menominee Nation of Wisconsin were growing tropical corn in Michigan's Upper Peninsula about 1,000 years ago. Last month Dartmouth researchers discovered the most complete ancient agricultural site so far in the eastern half of the U.S., along the Menominee River just across the Wisconsin border. Researchers said the Sixty Islands archaeological site features a raised ridge field system, with a more extensive maize, or corn, system than anyone imagined. It is a tropical plant, and many Western researchers previously believed it was mostly grown in tropical to subtropical regions. They were astounded that Menominee could grow so much in a cold climate with a relatively short growing season. 'The scale of this agricultural system by ancestral Menominee communities is 10 times larger than what was previously estimated,' said lead author Madeleine McLeester, an assistant professor of anthropology at Dartmouth, in a published article. 'That forces us to reconsider a number of preconceived ideas we have about agriculture not only in the region, but globally.' Beans and squash also were grown at the site, completing the 'Three Sisters' farming system created by Indigenous peoples. The crops work together naturally to protect each other from pests and disease. 'When you look at the scale of farming, this would require the kind of labor organization that is typically associated with a much larger, state-level hierarchical society,' said McLeester in the Dartmouth article. 'Yet, everything we know about this area suggests smaller egalitarian societies lived in this region. But, in fact, this may have been a rather large settlement.' The site is part of what's known to Menominee as Anaem Omot, translated to 'Dog's Belly,' and is where Menominee believe they were created near the mouth of the Menominee River at least 10,000 years ago. Along with raised ancient agricultural fields, the site also contains burial mounds, hammered metal artifacts, unmarked graves, ancient medicine lodges and dance rings associated with the Menominee Dream Dance. It remains a place of spiritual pilgrimage for Menominee living in Wisconsin. For years, the Menominee Nation has fought against mining at the site. Canada-based Aquila Resources had hoped to start its Back 40 Mine, which would extract gold, silver, zinc and copper. Aquila Resources was acquired in 2021 by Gold Resource Corporation. The Menominee has argued it would harm the environment, in particular affecting the region's water, which is historically significant to the tribe. With the help of Menominee Tribal Historic Preservation Officer David Grignon and the late archaeologist David Overstreet, the tribe was able to convince Western authorities to place the site on the National Register of Historic Places in 2023. The designation creates an extra layer of protection from harmful development. 'It was a long time in coming, but now our sacred sites, mounds and historic sites on the Menominee River at Sixty Islands are recognized,' Grignon said. Stefanie Tsosie, an attorney with Earthjustice, which has helped the tribe, said the historic designation is the same kind found in many cities usually represented by plaques on historic buildings. 'It doesn't outright prevent development,' she said. 'It's just an extra layer of regulation or extra layer of consideration that needs to happen.' This article originally appeared on Milwaukee Journal Sentinel: Menominee grew tropical corn farther in U.P., stunning researchers